The Effect of Empagliflozin on Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Pathway in Patients with Type 2 Cardiorenal Syndrome.

Autor: Pei Zhou1, Xiangyu Tang1 373609826@qq.com, Yunxia Deng1, Rong Wu1, Yuan Yi1, Hao Deng1, Qiongjiao Cao1
Zdroj: Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi. May2024, Vol. 28 Issue 5, p229-235. 7p.
Databáze: Academic Search Ultimate